HOME >> BIOLOGY >> NEWS
World Trade Center clean-up workers report acute respiratory problems

Many workers who cleared debris from the site of the World Trade Center attack of September 11 reported acute respiratory symptoms, according to a health assessment conducted by the Johns Hopkins Bloomberg School of Public Health. The investigators believe the respiratory problems may be associated with exposure to dust and airborne contaminants at "Ground Zero." Since the investigators only looked at short-term health effects, they said more research is needed to determine if there is any long-term health risk to the workers. The assessment was conducted in collaboration with the International Brotherhood of Teamsters and the findings were presented on August 22 at a meeting for members of Teamsters Local 282 and held in Lake Success, New York.

"Many of the workers we assessed reported coughing, wheezing, and sore throats while working at Ground Zero. These symptoms seemed to increase the longer they worked at the site. The good news is that we did not find unhealthy levels of asbestos, but we don't know what the long-term health risks may be regarding exposure to other airborne contaminants at the site," explains Alison S. Geyh, PhD, chief investigator and assistant professor of environmental health sciences at the Johns Hopkins Bloomberg School of Public Health.

The exposure and health assessment was conducted between October 2001 and April 2002. The investigators examined the workers' airborne exposures to asbestos, particulate matter, and volatile organic compounds. In October, airborne contaminants were measured at numerous locations at Ground Zero and on truck drivers who hauled wreckage away from the site. The respiratory health of the truck drivers and other debris-removal workers was assessed two months later. At that time, a respiratory health questionnaire was administered to the workers. In addition, lung function was measured using spirometry. Additional airborne contaminants measurements were collected in April and compared to what wa
'"/>

Contact: Tim Parsons or Kenna Brigham
paffairs@jhsph.edu
410-955-6878
Johns Hopkins University Bloomberg School of Public Health
23-Aug-2002


Page: 1 2

Related biology news :

1. OneWorld Health compiles comprehensive state of infectious diarrhea treatments, potential solutions
2. Institute for OneWorld Health nominated for the 2004 World Technology Awards
3. Institute for OneWorld Health receives Gates Foundation grant
4. OneWorld Health CEO outlines mutually beneficial collaborations between industry, nonprofits at BIO
5. Worlds largest scientific society convenes regional meeting June 2-4 in Indianapolis
6. Institute for OneWorld Health CEO to speak at BIO on leveraging opportunities for global health
7. OneWorld Health completes enrollment, treatment in Phase III India trial
8. Institute for OneWorld Health CEO advocates focus first on developing world markets
9. Worlds oldest modern hummingbirds described in Science
10. Worlds oldest mouse celebrates milestone birthday
11. Worlds largest tiger reserve declared in Myanmar

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/12/2019)... NEW PORT RICHEY, Fla. (PRWEB) , ... April ... ... Condition Targeted Nutraceuticals™ (CTNs), is excited to announce their efforts to help decrease ... will be available at no charge or a discounted rate, up to 50% ...
(Date:4/9/2019)... (PRWEB) , ... April 09, 2019 , ... The ... Certified Cancer Center following a rigorous and voluntary audit conducted by an independent, ... of only eight Novalis Certified Centers in the United States, McLeod is the only ...
(Date:4/4/2019)... ... April 02, 2019 , ... Orbsen Therapeutics, ... cell immunotherapies, announced it will move its base of operations from the National ... University’s newly created biotechnology park in Galway, Ireland. , “With four clinical trials ...
Breaking Biology News(10 mins):
(Date:4/8/2019)... ... April 08, 2019 , ... US Capital Global ... $15 million preferred equity investment in the privately held pharmaceutical company, S1 Biopharma (“S1”). ... Lorexys, is targeted at female hypoactive sexual dysfunction disorder and is ready to begin ...
(Date:4/4/2019)... ... April 03, 2019 , ... LeadingBiotech, an exclusive event ... today announces its Boston CEO conference to be held May 28-29, 2019 at ... opportunities with high-level panels and discussions from past, present and future change-makers. ...
(Date:3/27/2019)... ... 27, 2019 , ... In honor of National Nutrition Month, Lajollacooks4u has collaborated ... meals and good nutrition. This month, Chef Jodi Abel appeared on two segments ... , The first segment addressed the nutritional value of USDA’s MyPlate, a nutrition guide ...
(Date:3/23/2019)... PRUSSIA, Pa. (PRWEB) , ... March 22, 2019 ... ... introduction of its LenS3 Multi-Angle Light Scattering (MALS) detector , offering a ... (Rg) of synthetic polymers, polysaccharides, proteins, and biopolymers. A novel optical design, a ...
Breaking Biology Technology:
Cached News: